Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Theravance Biopharma (TBPH) Receivables - Net (2016 - 2019)

Theravance Biopharma (TBPH) has disclosed Receivables - Net for 7 consecutive years, with $87000.0 as the latest value for Q3 2019.

  • Quarterly Receivables - Net fell 97.12% to $87000.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $87000.0 through Sep 2019, down 97.12% year-over-year, with the annual reading at $620000.0 for FY2018, 72.48% down from the prior year.
  • Receivables - Net for Q3 2019 was $87000.0 at Theravance Biopharma, down from $111000.0 in the prior quarter.
  • The five-year high for Receivables - Net was $3.4 million in Q2 2018, with the low at $87000.0 in Q3 2019.
  • Average Receivables - Net over 5 years is $1.3 million, with a median of $1.2 million recorded in 2017.
  • The sharpest move saw Receivables - Net skyrocketed 18733.33% in 2015, then crashed 97.12% in 2019.
  • Over 5 years, Receivables - Net stood at $1.9 million in 2015, then tumbled by 66.39% to $646000.0 in 2016, then skyrocketed by 248.76% to $2.3 million in 2017, then plummeted by 72.48% to $620000.0 in 2018, then crashed by 85.97% to $87000.0 in 2019.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $87000.0, $111000.0, and $113000.0 for Q3 2019, Q2 2019, and Q1 2019 respectively.